杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Dec 6 2021

Full Issue

J&J Proves A Good Booster Choice For Pfizer Shot Recipients In Study

This is according to a small study from Boston, which looked at protection given by a J&J booster shot after getting two Pfizer shots originally. Separate news says covid shots give cancer patients good protection and that Pfizer may have a shot for under-5s ready soon.

People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson & Johnson booster shot as a Pfizer one. That鈥檚 the finding of a small study released on Sunday. Researchers at the Beth Israel Deaconess Medical Center in Boston studied 65 people who had received two shots of the Pfizer vaccine. Six months after the second dose, the researchers gave 24 of the volunteers a third dose of the Pfizer vaccine and gave 41 the Johnson & Johnson shot. (The study was funded in part by Johnson & Johnson and has not yet been published in a scientific journal.) (Zimmer, 12/5)

A new study found that the Johnson & Johnson COVID-19 vaccine serves as聽an effective booster on top of full vaccination from the Pfizer vaccine. A J&J booster, administered six months after two doses of the Pfizer vaccine, increased antibody and T-cell responses, according to the study, demonstrating potential benefits of mix-and-match boosters.聽鈥淭here is early evidence to suggest that a mix-and-match boosting approach may provide individuals with different immune responses against COVID-19 than a homologous boosting approach,鈥 said Dan Barouch, director of the center for virology and vaccine research at the Beth Israel Deaconess Medical Center. (Tebor and Bacon, 12/6)

In other vaccine development updates 鈥

A US Veterans Affairs (VA) study finds that the COVID-19 vaccine offered good protection against infection starting 2 weeks after the second dose in cancer patients, who are at increased risk for severe COVID-19.The retrospective nationwide study, published yesterday in JAMA Oncology, involved 29,152 vaccinated patients who received systemic cancer therapy at VA sites from Aug 15, 2010, to May 4, 2021. (12/3)

Pfizer could have data on COVID-19 vaccine efficacy for children under five by the end of the year, CEO Albert Bourla said on Friday in an interview with NBC News. Omicron has raised concerns that young children are becoming more vulnerable to the virus. Tshwane, the epicenter of South Africa's Omicron outbreak, has seen a high number of hospital admissions for children under two in the last few weeks, though scientists have not confirmed a link to the variant, Reuters reports. (Chen, 12/4)

And more on the vaccine rollout 鈥

About 1 in 420 Americans has died of covid-19, according to official data. And we鈥檙e still averaging more than 1,000 deaths per day. But in certain areas 鈥 and indeed in many areas in which the population is much more tightly packed and the coronavirus could transmit more easily 鈥 the story is far less grim. A big reason: widespread vaccination. Death rates are far below the national average in the most-vaccinated, often-urban areas. (Blake, 12/4)

A rush of vaccine-seeking customers and staff shortages are squeezing drugstores around the U.S., leading to frazzled workers and temporary pharmacy closures. Drugstores are normally busy this time of year with flu shots and other vaccines, but now pharmacists are doling out a growing number of COVID-19 shots and giving coronavirus tests. The push for shots is expected to grow more intense as President Joe Biden urges vaccinated Americans to get booster shots to combat the emerging omicron variant. The White House said Thursday that more than two in three COVID-19 vaccinations are happening at local pharmacies. (Murphy, 12/4)

Dania Palanker and her 7-year-old daughter, Nadia, felt excited as they bundled into the car in Washington last week to get Nadia鈥檚 coronavirus vaccine. The evening before, Palanker received an automated email from Walgreens confirming Nadia鈥檚 appointment at the chain鈥檚 outlet in Cheverly, Md. 鈥淲e鈥檒l see you tomorrow!鈥 read the subject line. Their anticipation turned to disappointment once they arrived for the 6:30 p.m. shot. The store was still open, but the pharmacists had left, the pharmacy counter was closed and no one could provide vaccines. The pharmacy shuttered a half-hour before Nadia鈥檚 confirmed appointment, part of service cutbacks by Walgreens caused by a labor shortage hitting drugstores across the country. (Rowland, 12/5)

KHN: Is It Time To Change The Definition Of 鈥楩ully Vaccinated鈥?聽

As more indoor venues require proof of vaccination for entrance and with winter 鈥 as well as omicron, a new covid variant 鈥 looming, scientists and public health officials are debating when it will be time to change the definition of 鈥渇ully vaccinated鈥 to include a booster shot. It鈥檚 been more than six months since many Americans finished their vaccination course against covid; statistically, their immunity is waning. (Knight, 12/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 2
  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF